October: A Month to Act with Awareness and Knowledge
Breast Cancer Awareness Month reminds us every year of the importance of early detection and prevention — but also of the power of knowledge.
While mammography and regular screenings are essential for identifying tumors early, genetic testing helps us understand why cancer develops and how to prevent it before it starts.
At Alfadiag, we believe that awareness must go hand in hand with scientific precision. Through our collaboration with global leaders in genomics such as BGI, we provide comprehensive hereditary cancer testing that helps women and men identify their inherited risk for breast, ovarian, prostate, and related cancers.
Why Genetic Testing Matters
Approximately 5–10% of breast cancers are hereditary, caused by mutations passed down through families.
The most well-known of these are BRCA1 and BRCA2 gene mutations, which significantly increase the lifetime risk of breast and ovarian cancers.
However, there are many other genes — including TP53, CHEK2, PALB2, and others — that may also contribute to elevated cancer risk.
Knowing your genetic status allows both doctors and patients to make informed decisions about:
Early and more frequent screening (MRI, ultrasound, or mammogram)
Preventive measures or lifestyle changes to lower risk
Targeted therapy options for patients already diagnosed
Family risk assessment for relatives who may also carry similar mutations
Genetic Insights for Targeted Treatment
Modern cancer care is shifting from “one-size-fits-all” approaches to precision oncology.
Genetic testing not only predicts risk but also guides treatment.
For example, patients with BRCA1/2 mutations may respond better to PARP inhibitors, while other gene alterations may qualify patients for specific targeted therapies.
At Alfadiag, our BGI Hereditary Cancer Panels combine comprehensive gene coverage with advanced sequencing technology, enabling clinicians to identify actionable mutations for personalized treatment strategies.
Who Should Consider Testing?
Genetic testing is recommended for individuals who:
Have a family history of breast, ovarian, prostate, or colon cancer
Were diagnosed with breast cancer before age 50
Have multiple relatives with the same or related cancers
Are interested in preventive health management or family planning
Alfadiag’s Commitment to Early Detection
During this Pink October, Alfadiag is offering special prices on Hereditary Cancer Panels, including:
Female panel (85 genes)
Male panel (90 genes)
BRCA1 & BRCA2 testing
Breast and Ovarian Cancer panel
Our tests are performed in collaboration with BGI, one of the world’s most advanced genomic laboratories, ensuring accuracy, quality, and comprehensive reporting.
Take Charge of Your Health
Genetic testing is more than a diagnostic tool — it’s a proactive step toward a healthier future.
By understanding your genetic risk, you can act earlier, make smarter health decisions, and protect not only yourself but also your family.
To know more about our Hereditary Cancer Testing: https://alfadiag.com/products/oncology-genetic-tests/hereditary-cancer-screening/